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These are GXW and TDY (where X is usually acidic) [ 11. X-ray crystallography of several members of the family revealed that they exhibit a high degree of three-dimensional structural similarity, with the common structure motifs occupying identical spatial positions. The basic core of the structure is a /?-barrel with eight antiparallel Bstrands that fold into an orthogonal calyx [2, 31 . The B-barrel is lined internally by many hydrophobic residues that confer ligand specificity. The highest degree of variation is found in the size, amino-acid sequence and spatial positions of loops that connect the /?-strands. This suggests that these loops may represent regions that are involved in the functional properties of particular proteins. We demonstrate this by taking human serum retinol-binding protein (RBP) as an example.
RHP transports retinol from the liver to tissues requiring vitamin A. In the plasma, most RBP is found as a complex with another protein that is called transthyretin (TTR; for a review, see [4] ). We have previously demonstrated that the transfer of retinol from RBP to vitamin-A-requiring cells involves the specific interaction of RBP with a plasma-membrane-bound receptor [ 51. The transfer of retinol to the target cell leaves RBP in a form that has a much reduced affinity for the receptor [6] , as well as for TTR, and hence the protein is lost by glomerular filtration. This process causes a shift in the equilibrium TTR-RBP + TTR + RBP, ensuring the availability of free RBP for the further delivery of retinol. The structural changes that render RHP inactive in this way have yet to be established.
Thus RBP, in addition to binding retinol, exhibits two other molecular-recognition properties, that is, it interacts with TTR and with the membrane receptor. Residues of RBP that are involved in the interaction with retinol have been identified by 
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X-ray crystallography [2, 61 . Such an approach should be feasible with the RBP-TTR complex, but there are, as yet, no reports of successful crystallization of this complex. With respect to the RBP-receptor complex, the receptor has to be purified first in sufficient quantity to allow crystallization trials. We therefore used a combination of biochemical and recombinant DNA approaches to identify regions of RBP that are involved in the interaction with TTR and with the receptor. membrane receptor (indeed in this respect it was more active than the protein isolated from serum).
Structure-function of RBP
Following successful expression of fully functional RRP, we introduced several site-specific substitutions and deletions into the RRP cDNA, to help identify the residues/regions of RBP that are involved in binding to TTR and to the receptor. The /?-barrel was left unchanged to preserve the retinol-binding ability, which appears to be necessary for the efficient interaction with TTR and with the receptor. The result indicated that, of the three loops (residues 31-37,62-68 and 92-98) that make up the entrance to the 'retinol-binding pocket', residues 62-68 and 92-98 are heavily involved in the interaction with TTR and with the RBP receptor. However, there are subtle differences: the conversion of the two leucine residues L63 and L64 to arginine and serine respectively, abolished the binding of RBP to the receptor completely, but only partially abolished the binding to TTR. The converse is true with the loop 92-98. Deletion of residues 92-98 abolished the binding of RBP to TTR completely, and substantially reduced its affinity for the receptor. Altering the leucine L35 to proline marginally reduced RHP binding to TTR, but had no effect on the interaction with the receptor. The results clearly indicate that the regions of RBP that are involved in binding to T T R and to the receptor are similar, but not identical. This has two implications. Firstly, RHP, as long as it is complexed with TTR, is incapable of binding to the receptor. This is consistent with our earlier observations that TTR inhibits RRP binding to the receptor, and reduces the rate of receptor-mediated uptake of retinol (from RBP) by membrane vesicles [7] . Secondly, binding to the receptor via the loop regions is also consistent with the postulated biochemical mechanism in which RBP releases its retinol to the membrane after RBP-receptor interaction [7] . Figure 2 summarizes the results of the mutagenic study, illustrating the residues/regions of RBP involved in the interaction with TTR and with the receptor. We would put forward the suggestion that this type of mechanism, new to eukaryotic biology, may occur for other, particularly hydrophobic, ligands, such as steroid hormones.
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Purification of the RBP receptor
We have purified the RBP receptor protein from human placental membranes using an affinity resin made by coupling recombinant RBP to Sepharose 4B. The receptor, in an octyl glucoside extract of the membrane, is allowed to interact with the affinity resin and is specifically eluted with an ion-free soh- found to consist of a major 63 kDa species and a minor 55 kDa band in SDS/PAGE. The relationship of the minor to the major component of the receptor remains to be established, although its absence in stoichiometric amounts suggests that the receptor is unlikely to be a hetero-oligomer. Protein-sequence analysis of the 63 kDa band revealed that its N-terminus is blocked. From a V, protease cleavage product, some internal protein-sequence data were obtained that showed that the RBP receptor has a limited degree of similarity with the fibroblast-growth-factor receptor and with the androgen receptor. Further sequence data will be required before this similarity can be confirmed.
Mechanism of receptor-mediated retinol transport
Using gel filtration, we have identified in placental membranes a protein of 15 kDa that binds retinol specifically and that is extractable by EDTA. We believe that this extrinsic protein, which is similar in size to cellular RBP (CRBP) probably serves as an acceptor for retinol at the cytoplasmic face of the plasma membrane, when retinol is delivered by serum RBP via the receptor. Immunocytochemical studies by previous workers [8] have suggested an association between CRBP and the cytoplasmic surface of the plasma membrane. Ottonello et al. [9] also demonstrated the association of CRBP with bovine-pigment epithelial cell membranes, using EDTA extraction of extrinsic proteins. Thus, comVolume 21 [7-lo] , the following mechanism can be advanced to account for receptor-mediated retinol uptake by cells (Figure 3) . Firstly, RBP binds to its receptor on the plasma membrane, triggering some form of conformational change that facilitates the release of retinol from the binding pocket, possibly to the receptor or to an associated transport protein.
CRBP, or a protein of similar size, perhaps interacting at the cytoplasmic side of the receptor, receives this retinol. The binding of retinol to CRBP then causes dissociation of the retinol-CRBP complex from the membrane. Such a mechanism will prevent the diffusion of retinol to the lipid bilayer during its transport across the plasma membrane. Indeed, when delivered via RBP, it is striking that the released retinol become protein-bound rather Table 2 Lipocalin specificity of the OBP receptor 
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The discovery of a receptor for OBP is important in that it reinforces our observations with RBP, and points to a new superfamily of receptors with a unique role. Cloning, expression and mutagenesis of lipocalins and their corresponding receptors will help elucidate the exact nature of this role.
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